Suppr超能文献

留置腹膜和胸膜导管在恶性和非恶性腹水及胸腔积液管理中的应用:来自丹麦一家三级中心的经验

Indwelling peritoneal and pleural catheters in the management of malignant and non-malignant ascites and pleural effusion: experiences from a Danish tertiary center.

作者信息

Thøgersen Amalie, Kristiansen Bo, Løkke Anders, Hilberg Ole, Borg Morten

机构信息

Department of Medicine, Lillebaelt Hospital Vejle, University Hospital of Southern Denmark, Vejle, Denmark.

Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

出版信息

Eur Clin Respir J. 2025 Jul 23;12(1):2529053. doi: 10.1080/20018525.2025.2529053. eCollection 2025.

Abstract

Recurrent pleural effusions and ascites significantly impair quality of life, particularly in patients with advanced malignant and non-malignant disease. Traditional management often relies on repeated hospital-based procedures, which provide temporary symptom relief but place a considerable burden on patients and healthcare systems. This retrospective cohort study evaluates the safety, effectiveness, and clinical outcomes of indwelling pleural and peritoneal catheters (IPCs and IPeCs) in 63 patients treated at Lillebaelt Hospital Vejle between October 2019 and October 2024. A total of 30 patients received IPCs and 33 received IPeCs. Most had malignant effusions or ascites, but a notable proportion had non-malignant causes such as heart failure, liver cirrhosis, or renal disease. Following catheter placement, median survival was 45 days for IPC patients and 34 days for IPeC patients. Infection rates were low: 17% of IPC patients developed superficial skin infections, all treated successfully with oral antibiotics, and 6% of IPeC patients developed peritonitis, with one case potentially unrelated to the catheter. Importantly, 70% of IPC and 76% of IPeC patients had no hospital visits due to catheter-related complications, supporting the safety and outpatient feasibility of these devices. Additionally, a substantial proportion of patients-23% (IPC) and 30% (IPeC) - were able to remain in their own homes, potentially with support from home care services, rather than requiring institutionalization. These findings underline the benefit of early catheter placement in supporting patient autonomy and symptom control. Our results confirm that IPCs and IPeCs are safe and effective for managing both malignant and non-malignant effusions, with low complication rates and high patient benefit. Our findings support broader use of these catheters in palliative care. Earlier consideration of catheter placement may further improve outcomes and quality of life.

摘要

复发性胸腔积液和腹水会显著损害生活质量,尤其是晚期恶性和非恶性疾病患者。传统治疗通常依赖于反复的住院治疗,虽能暂时缓解症状,但给患者和医疗系统带来了相当大的负担。这项回顾性队列研究评估了2019年10月至2024年10月在里伯厄尔州韦杰勒医院接受治疗的63例患者中留置胸腔和腹腔导管(IPCs和IPeCs)的安全性、有效性和临床结果。共有30例患者接受了IPCs,33例接受了IPeCs。大多数患者有恶性胸腔积液或腹水,但相当一部分患者有非恶性病因,如心力衰竭、肝硬化或肾病。导管置入后,IPCs患者的中位生存期为45天,IPeCs患者为34天。感染率较低:17%的IPCs患者发生浅表皮肤感染,均通过口服抗生素成功治疗,6%的IPeCs患者发生腹膜炎,其中1例可能与导管无关。重要的是,70%的IPCs患者和76%的IPeCs患者没有因导管相关并发症而住院,这证明了这些装置的安全性和门诊可行性。此外,相当一部分患者(IPCs为23%,IPeCs为30%)能够居家,可能在家护服务的支持下,而无需住院。这些发现强调了早期放置导管在支持患者自主性和症状控制方面的益处。我们的结果证实,IPCs和IPeCs在管理恶性和非恶性胸腔积液方面是安全有效的,并发症发生率低,患者受益高。我们的发现支持在姑息治疗中更广泛地使用这些导管。更早考虑放置导管可能会进一步改善治疗结果和生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7233/12288166/2237d640bdfb/ZECR_A_2529053_F0001_OC.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验